"El Instituto Oncológico de Córdoba fue creado el 27 de Mayo de 2005 por el Prof. Dr. Eduardo Richardet con el objetivo de desarrollar un lugar especializado en el tratamiento y prevención del cáncer. Integrado en un espacio asistencial de primer nivel, orienta al tratamiento oncológico de manera multidisciplinaria, a través de la atención de profesionales especializados, fundado en la calidad humana y científica."

During the past decade, Instituto Oncológico de Córdoba (IONC) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Oncológico de Córdoba (IONC)" #1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Oncológico de Córdoba (IONC)" are "Chemotherapy-Induced Nausea and Vomiting" (1 trials) and "Small-cell Lung Cancer" (1 trials). Many other conditions were trialed in "Instituto Oncológico de Córdoba (IONC)" in a lesser frequency.

Most popular intervention types in "Instituto Oncológico de Córdoba (IONC)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide (CTX)" (1 trials), "Dexamethasone" (1 trials), "Doxorubicin (DOX)" (1 trials), "I.V. palonosetron" (1 trials) and "Lurbinectedin (PM01183)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Oncológico de Córdoba (IONC)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Oncológico de Córdoba (IONC)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto Oncológico de Córdoba (IONC), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Oncológico de Córdoba (IONC), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".